Valuation: Makers Laboratories Limited

Market Cap 798M 8.45M 7.43M 6.84M 6.4M 12M 12.22M 82.09M 31.8M 393M 31.75M 31.05M 1.37B P/E 2024
-10.6x
P/E 2025 10.2x
Enterprise Value 846M 8.96M 7.87M 7.26M 6.78M 12.72M 12.96M 87.05M 33.72M 417M 33.67M 32.93M 1.45B EV / Sales 2024
0.78x
EV / Sales 2025 0.67x
Free-Float
32.66%
Yield 2024 *
-
Yield 2025 -
05-26 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-10 Makers Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-07 Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/08/25 CARE Affirms BBB+ Rating on Makers Laboratories' Long-Term Bank Financing; Outlook Stable MT
08/08/25 Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
08/08/25 Makers Laboratories Returns to Consolidated Profit in Fiscal Q1; Shares Slide MT
26/05/25 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
29/10/24 Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
06/08/24 Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
23/05/24 Makers Laboratories Gets Board Nod to Sell Mumbai, India Property to Ipca Laboratories MT
23/05/24 Makers Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
23/05/24 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
15/02/24 Makers Laboratories Limited Announces the Resignation of Ms. Surbhi Sharma as Company Secretary / Compliance Officer, Effective March 13, 2024 CI
1 day+0.96%
1 week-0.44%
Current month-10.05%
1 month-8.68%
3 months-3.06%
6 months+28.03%
Current year+24.67%
1 week 140.95
Extreme 140.95
153.95
1 month 138
Extreme 138
178
Current year 112.1
Extreme 112.1
186.7
1 year 109
Extreme 109
186.7
3 years 98.05
Extreme 98.05
230
5 years 94
Extreme 94
238
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Chief Executive Officer 51 11/08/2011
Director of Finance/CFO 59 30/10/2017
Compliance Officer - 23/05/2024
Director TitleAgeSince
Director/Board Member 79 29/04/2009
Chairman 77 28/03/2019
Director/Board Member 51 11/08/2011
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%-0.44%-2.45%+35.32% 9.13M
-0.62%+2.08%+11.57%+87.89% 47.71B
+0.37%+3.47%+53.26%+102.19% 35.38B
+0.15%+6.24%-4.63%+45.55% 12.32B
+0.19%+2.51%+12.99%+97.70% 11.74B
-0.57%0.00%+37.80%+122.46% 9.02B
+1.17%+3.94%+20.56%+43.58% 6.98B
+0.15%+4.22%+52.70%-13.19% 6.83B
-1.20%+0.02%+25.47%+240.35% 6.53B
-0.19%+3.19%-32.62%+1.33% 5.14B
Average +0.04%+2.63%+17.46%+76.32% 14.17B
Weighted average by Cap. -0.12%+3.14%+23.82%+87.62%

Financials

2024 2025
Net sales 1.04B 11.06M 9.72M 8.95M 8.37M 15.7M 15.99M 107M 41.61M 515M 41.54M 40.63M 1.79B 1.21B 12.8M 11.24M 10.36M 9.68M 18.16M 18.5M 124M 48.13M 595M 48.06M 47M 2.07B
Net income -62.64M -664K -583K -537K -502K -942K -959K -6.45M -2.5M -30.88M -2.49M -2.44M -107M 74.91M 794K 697K 642K 601K 1.13M 1.15M 7.71M 2.99M 36.92M 2.98M 2.92M 128M
Net Debt 149M 1.58M 1.38M 1.28M 1.19M 2.24M 2.28M 15.3M 5.93M 73.29M 5.92M 5.79M 255M 48.19M 511K 449K 413K 386K 725K 738K 4.96M 1.92M 23.76M 1.92M 1.88M 82.56M
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
131
Date Price Change Volume
25/06/26 ₹147.30 +0.96% 1,201
24/06/26 ₹145.90 +1.85% 2,961
23/06/26 ₹143.25 -3.08% 5,813
22/06/26 ₹147.80 -2.09% 5,772
19/06/26 ₹150.95 +2.03% 10,066
  1. Stock Market
  2. Stocks
  3. MAKERSL6 Stock